Treatment outcomes in oligometastatic non ‐small‐cell lung cancer: a single centre experience

ConclusionIn well ‐selected NSCLC patients with limited metastasis, survival rates can reach up to 3 y, even in a geriatric population. Clinical N staging and co‐morbidity are important prognostic factors.

Source: The Clinical Respiratory Journal - February 7, 2020 Category: Respiratory Medicine Authors: P ınar Akın Kabalak, Derya Kızılgöz, Ülkü Yılmaz, Tuba İnal Cengiz, Evrim Tunç, Şebnem Yaman, Erkmen Gülhan Tags: ORIGINAL ARTICLE Source Type: research